
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-a68b4900.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-0a3f24ce.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Sebelipase Alfa Improves Aminotransferase Levels in Lysosomal Acid Lipase Deficiency: Data From an International Registry - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="FF2081B089B735831A81B000383A3610.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="blackwellopen">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12334869/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Liver International">
<meta name="citation_title" content="Sebelipase Alfa Improves Aminotransferase Levels in Lysosomal Acid Lipase Deficiency: Data From an International Registry">
<meta name="citation_author" content="Lorenzo D&#x27;Antiga">
<meta name="citation_author_institution" content="Department of Medicine and Surgery, University of Milano–Bicocca, Milan, Italy">
<meta name="citation_author_institution" content="Pediatric Hepatology, Gastroenterology and Transplantation, Hospital Papa Giovanni XXIII, Bergamo, Italy">
<meta name="citation_author" content="Jennifer Evans">
<meta name="citation_author_institution" content="Department of Epidemiology, Alexion, AstraZeneca Rare Disease, Boston, Massachusetts, USA">
<meta name="citation_author" content="Emilio Ros">
<meta name="citation_author_institution" content="Institut D&#x27;investigacions Biomèdiques August Pi Sunyer (IDIBAPS), hospital Clinic, Barcelona, Spain">
<meta name="citation_author" content="Florian Abel">
<meta name="citation_author_institution" content="Department of Global Medical Affairs, Alexion, AstraZeneca Rare Disease, Boston, Massachusetts, USA">
<meta name="citation_author" content="Manisha Balwani">
<meta name="citation_author_institution" content="Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA">
<meta name="citation_author" content="Don P Wilson">
<meta name="citation_author_institution" content="Endocrinology, Cook Children&#x27;s Medical Center, Fort Worth, Texas, USA">
<meta name="citation_author" content="William Balistreri">
<meta name="citation_author_institution" content="UC Department of Pediatrics, Cincinnati Children&#x27;s Hospital Medical Center, Cincinnati, Ohio, USA">
<meta name="citation_publication_date" content="2025 Aug 8">
<meta name="citation_volume" content="45">
<meta name="citation_issue" content="9">
<meta name="citation_firstpage" content="e70279">
<meta name="citation_doi" content="10.1111/liv.70279">
<meta name="citation_pmid" content="40781810">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12334869/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12334869/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12334869/pdf/LIV-45-0.pdf">
<meta name="description" content="In patients with lysosomal acid lipase deficiency (LAL‐D), elevations in alanine and aspartate aminotransferases (ALT, AST) are associated with liver damage. The objective of this analysis was to evaluate aminotransferase levels in patients treated ...">
<meta name="og:title" content="Sebelipase Alfa Improves Aminotransferase Levels in Lysosomal Acid Lipase Deficiency: Data From an International Registry">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="In patients with lysosomal acid lipase deficiency (LAL‐D), elevations in alanine and aspartate aminotransferases (ALT, AST) are associated with liver damage. The objective of this analysis was to evaluate aminotransferase levels in patients treated ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12334869/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-testid="header" data-header >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            
                <a class="ncbi-header__logo-container" href="https://www.ncbi.nlm.nih.gov/">
                    <img alt="
                                  NCBI home page
                              "
                         class="ncbi-header__logo-image"
                         src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg" />
                </a>
            

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-testid="searchPanel"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      aria-describedby="search-field-desktop-navigation-help-text"
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only"
                           data-testid="label"
                           for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           data-testid="textInput"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    data-testid="button"
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  role="search">
                <label class="usa-sr-only" for="search-field">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="search" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        <a class="usa-link" href="https://www.ncbi.nlm.nih.gov/pmc/advanced/" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12334869">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1111/liv.70279"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/LIV-45-0.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12334869%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12334869/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12334869/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12334869/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-blackwellopen.png" alt="Wiley Open Access Collection logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Wiley Open Access Collection" title="Link to Wiley Open Access Collection" shape="default" href="https://doi.org/10.1111/liv.70279" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Liver Int</button></div>. 2025 Aug 8;45(9):e70279. doi: <a href="https://doi.org/10.1111/liv.70279" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1111/liv.70279</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Liver%20Int%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liver%20Int%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Liver%20Int%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Liver%20Int%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Sebelipase Alfa Improves Aminotransferase Levels in Lysosomal Acid Lipase Deficiency: Data From an International Registry</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22D'Antiga%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Lorenzo D'Antiga</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Lorenzo D'Antiga</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Department of Medicine and Surgery, University of Milano–Bicocca, Milan, Italy</div>
<div class="p">
<sup>
<sup>2</sup>
</sup>Pediatric Hepatology, Gastroenterology and Transplantation, Hospital Papa Giovanni XXIII, Bergamo, Italy</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22D'Antiga%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Lorenzo D'Antiga</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Evans%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Jennifer Evans</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Jennifer Evans</span></h3>
<div class="p">
<sup>
<sup>3</sup>
</sup>Department of Epidemiology, Alexion, AstraZeneca Rare Disease, Boston, Massachusetts, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Evans%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jennifer Evans</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ros%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Emilio Ros</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Emilio Ros</span></h3>
<div class="p">
<sup>
<sup>4</sup>
</sup>Institut D'investigacions Biomèdiques August Pi Sunyer (IDIBAPS), hospital Clinic, Barcelona, Spain</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ros%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Emilio Ros</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Abel%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Florian Abel</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Florian Abel</span></h3>
<div class="p">
<sup>
<sup>5</sup>
</sup>Department of Global Medical Affairs, Alexion, AstraZeneca Rare Disease, Boston, Massachusetts, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Abel%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Florian Abel</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Balwani%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Manisha Balwani</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Manisha Balwani</span></h3>
<div class="p">
<sup>
<sup>6</sup>
</sup>Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Balwani%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Manisha Balwani</span></a>
</div>
</div>
<sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wilson%20DP%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Don P Wilson</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Don P Wilson</span></h3>
<div class="p">
<sup>
<sup>7</sup>
</sup>Endocrinology, Cook Children's Medical Center, Fort Worth, Texas, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wilson%20DP%22%5BAuthor%5D" class="usa-link"><span class="name western">Don P Wilson</span></a>
</div>
</div>
<sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Balistreri%20W%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">William Balistreri</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">William Balistreri</span></h3>
<div class="p">
<sup>
<sup>8</sup>
</sup>UC Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Balistreri%20W%22%5BAuthor%5D" class="usa-link"><span class="name western">William Balistreri</span></a>
</div>
</div>
<sup>8</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="liv70279-aff-0001">
<sup>
<sup>1</sup>
</sup>Department of Medicine and Surgery, University of Milano–Bicocca, Milan, Italy</div>
<div id="liv70279-aff-0002">
<sup>
<sup>2</sup>
</sup>Pediatric Hepatology, Gastroenterology and Transplantation, Hospital Papa Giovanni XXIII, Bergamo, Italy</div>
<div id="liv70279-aff-0003">
<sup>
<sup>3</sup>
</sup>Department of Epidemiology, Alexion, AstraZeneca Rare Disease, Boston, Massachusetts, USA</div>
<div id="liv70279-aff-0004">
<sup>
<sup>4</sup>
</sup>Institut D'investigacions Biomèdiques August Pi Sunyer (IDIBAPS), hospital Clinic, Barcelona, Spain</div>
<div id="liv70279-aff-0005">
<sup>
<sup>5</sup>
</sup>Department of Global Medical Affairs, Alexion, AstraZeneca Rare Disease, Boston, Massachusetts, USA</div>
<div id="liv70279-aff-0006">
<sup>
<sup>6</sup>
</sup>Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA</div>
<div id="liv70279-aff-0007">
<sup>
<sup>7</sup>
</sup>Endocrinology, Cook Children's Medical Center, Fort Worth, Texas, USA</div>
<div id="liv70279-aff-0008">
<sup>
<sup>8</sup>
</sup>UC Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA</div>
<div class="author-notes p">
<div class="fn" id="correspondenceTo">
<sup>*</sup><p class="display-inline">

<strong>Correspondence:</strong>
 
Lorenzo D'Antiga (<span>ldantiga@asst-pg23.it</span>)
</p>
</div>
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Revised 2025 Jul 28; Received 2024 Nov 12; Accepted 2025 Jul 31; Issue date 2025 Sep.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 The Author(s). <em>Liver International</em> published by John Wiley &amp; Sons Ltd.</div>
<p>This is an open access article under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12334869  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40781810/" class="usa-link">40781810</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>ABSTRACT</h2>
<section id="liv70279-sec-0001"><h3 class="pmc_sec_title">Background and Aims</h3>
<p>In patients with lysosomal acid lipase deficiency (LAL‐D), elevations in alanine and aspartate aminotransferases (ALT, AST) are associated with liver damage. The objective of this analysis was to evaluate aminotransferase levels in patients treated with sebelipase alfa enzyme replacement therapy and untreated patients.</p></section><section id="liv70279-sec-0002"><h3 class="pmc_sec_title">Methods</h3>
<p>Patients in this observational study were from the International LAL‐D Registry and included untreated and treated patients who started sebelipase alfa at age ≥ 6 months. Patients in the longitudinal analysis must have had baseline and longitudinal measures of ALT or AST. A subanalysis was performed on data from patients with 3 consecutive annual follow‐up measures.</p></section><section id="liv70279-sec-0003"><h3 class="pmc_sec_title">Results</h3>
<p>Of 186 patients included in this analysis, 125 were treated with sebelipase alfa. Median age at diagnosis was 9.1 y for treated patients and 20.6 y for untreated patients. Baseline ALT levels were above the upper limit of normal in 93% of children aged &lt; 18 years and 68% of adults aged ≥ 18 years. Among 53 treated patients who had ALT results reported at 3 consecutive annual measurements, 22 (42%) had ALT levels within normal limits after 1 year of sebelipase alfa treatment. Results were similar for AST. A repeated measures regression model of data from treated patients showed significant reductions from baseline in both ALT and AST levels across 3 years of the study. Untreated patients had no appreciable changes in aminotransferase elevations over time.</p></section><section id="liv70279-sec-0004"><h3 class="pmc_sec_title">Conclusions</h3>
<p>Aminotransferase levels were elevated in most patients with LAL‐D at baseline. There were sustained improvements with sebelipase alfa treatment.</p></section><section id="liv70279-sec-0005"><h3 class="pmc_sec_title">Trial Registration</h3>
<p>International LAL‐D Registry: <a href="https://clinicaltrials.gov/ct2/show/NCT01633489" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT01633489</a>, EUPAS13276</p></section><section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> alanine aminotransferase, aspartate aminotransferase, enzyme replacement therapy, lysosomal acid lipase deficiency</p></section></section><hr class="headless">
<h3>Abbreviations</h3>
<dl class="def-list" id="liv70279-dl-0001">
<dt id="liv70279-li-0001">AE</dt>
<dd id="liv70279-li-0002"><p>adverse event</p></dd>
<dt id="liv70279-li-0003">ALT</dt>
<dd id="liv70279-li-0004"><p>alanine aminotransferase</p></dd>
<dt id="liv70279-li-0005">AST</dt>
<dd id="liv70279-li-0006"><p>aspartate aminotransferase</p></dd>
<dt id="liv70279-li-0007">ERT</dt>
<dd id="liv70279-li-0008"><p>enzyme‐replacement therapy</p></dd>
<dt id="liv70279-li-0009">LAL‐D</dt>
<dd id="liv70279-li-0010"><p>lysosomal acid lipase deficiency</p></dd>
<dt id="liv70279-li-0011">Nobs</dt>
<dd id="liv70279-li-0012"><p>number of observations</p></dd>
<dt id="liv70279-li-0013">Q1, Q3</dt>
<dd id="liv70279-li-0014"><p>first and third quarters</p></dd>
<dt id="liv70279-li-0015">SAE</dt>
<dd id="liv70279-li-0016"><p>serious adverse event</p></dd>
<dt id="liv70279-li-0017">ULN</dt>
<dd id="liv70279-li-0018"><p>upper limit of normal</p></dd>
<dt id="liv70279-li-0019">WNL</dt>
<dd id="liv70279-li-0020"><p>within normal limits</p></dd>
</dl>
<section class="bt xbox font-sm" id="liv70279-blkfxd-0001"><h2 class="obj_head">Summary.</h2>
<ul id="liv70279-list-0001" class="list" style="list-style-type:disc">
<li id="liv70279-li-0021"><p>Liver damage is common among people with lysosomal acid lipase deficiency (LAL‐D), especially those who are diagnosed with the disease early in life.</p></li>
<li id="liv70279-li-0022"><p>Enzyme replacement therapy with sebelipase alfa can normalise blood markers of liver damage, suggesting that the treatment helps to protect the liver in these patients.</p></li>
<li id="liv70279-li-0023"><p>Since liver damage can be life‐threatening, protecting the liver with sebelipase alfa treatment may improve outcomes in people with LAL‐D.</p></li>
</ul></section><section id="liv70279-sec-0009"><h2 class="pmc_sec_title">1. Introduction</h2>
<p>Lysosomal acid lipase deficiency (LAL‐D) is a rare autosomal recessive lysosomal storage disorder caused by pathogenic variants in <em>LIPA</em>, resulting in diminished or absent LAL activity [<a href="#liv70279-bib-0001" class="usa-link" aria-describedby="liv70279-bib-0001">1</a>, <a href="#liv70279-bib-0002" class="usa-link" aria-describedby="liv70279-bib-0002">2</a>, <a href="#liv70279-bib-0003" class="usa-link" aria-describedby="liv70279-bib-0003">3</a>]. Loss of LAL activity leads to lysosomal accumulation of the LAL substrates triglyceride and cholesteryl ester in organs and tissues, especially in the liver, spleen, gut, and cardiovascular system [<a href="#liv70279-bib-0001" class="usa-link" aria-describedby="liv70279-bib-0001">1</a>, <a href="#liv70279-bib-0003" class="usa-link" aria-describedby="liv70279-bib-0003">3</a>, <a href="#liv70279-bib-0004" class="usa-link" aria-describedby="liv70279-bib-0004">4</a>, <a href="#liv70279-bib-0005" class="usa-link" aria-describedby="liv70279-bib-0005">5</a>]. The clinical manifestations of LAL‐D vary by age of symptom onset. Patients who manifest symptoms of LAL‐D in early infancy can present with rapidly progressive disease characterised by hepatosplenomegaly, abdominal distention, macrophage‐driven inflammation, vomiting, diarrhoea, and failure to thrive and typically do not survive beyond the first year of life [<a href="#liv70279-bib-0001" class="usa-link" aria-describedby="liv70279-bib-0001">1</a>, <a href="#liv70279-bib-0003" class="usa-link" aria-describedby="liv70279-bib-0003">3</a>, <a href="#liv70279-bib-0006" class="usa-link" aria-describedby="liv70279-bib-0006">6</a>]. Patients who manifest symptoms of LAL‐D in childhood and adulthood can present with hepatomegaly, elevated aminotransferase levels, liver dysfunction, lobular inflammation, elevated total and low‐density lipoprotein cholesterol levels, low high‐density lipoprotein cholesterol levels and, in some patients, accumulation of cholesterol ester and carotene in the intestinal mucosa [<a href="#liv70279-bib-0001" class="usa-link" aria-describedby="liv70279-bib-0001">1</a>, <a href="#liv70279-bib-0003" class="usa-link" aria-describedby="liv70279-bib-0003">3</a>, <a href="#liv70279-bib-0004" class="usa-link" aria-describedby="liv70279-bib-0004">4</a>, <a href="#liv70279-bib-0007" class="usa-link" aria-describedby="liv70279-bib-0007">7</a>, <a href="#liv70279-bib-0008" class="usa-link" aria-describedby="liv70279-bib-0008">8</a>, <a href="#liv70279-bib-0009" class="usa-link" aria-describedby="liv70279-bib-0009">9</a>]. These clinical manifestations may progress over time to liver fibrosis, cirrhosis, and the need for liver transplantation, as well as premature atherosclerosis [<a href="#liv70279-bib-0001" class="usa-link" aria-describedby="liv70279-bib-0001">1</a>, <a href="#liv70279-bib-0002" class="usa-link" aria-describedby="liv70279-bib-0002">2</a>, <a href="#liv70279-bib-0010" class="usa-link" aria-describedby="liv70279-bib-0010">10</a>, <a href="#liv70279-bib-0011" class="usa-link" aria-describedby="liv70279-bib-0011">11</a>]. The diagnosis of LAL‐D is often missed or delayed, which may be a result of a clinical picture that overlaps with that of other more common conditions, such as familial hypercholesterolaemia or metabolic dysfunction–associated steatotic liver disease [<a href="#liv70279-bib-0001" class="usa-link" aria-describedby="liv70279-bib-0001">1</a>, <a href="#liv70279-bib-0002" class="usa-link" aria-describedby="liv70279-bib-0002">2</a>, <a href="#liv70279-bib-0007" class="usa-link" aria-describedby="liv70279-bib-0007">7</a>, <a href="#liv70279-bib-0008" class="usa-link" aria-describedby="liv70279-bib-0008">8</a>].</p>
<p>Sebelipase alfa (KANUMA, Alexion, AstraZeneca Rare Disease) is a human LAL enzyme‐replacement therapy (ERT) approved for treatment of LAL‐D in more than 30 countries, including the United States, Canada, Japan, Australia, Israel, Saudi Arabia, the United Kingdom, and the countries in the European Union [<a href="#liv70279-bib-0012" class="usa-link" aria-describedby="liv70279-bib-0012">12</a>, <a href="#liv70279-bib-0013" class="usa-link" aria-describedby="liv70279-bib-0013">13</a>, <a href="#liv70279-bib-0014" class="usa-link" aria-describedby="liv70279-bib-0014">14</a>, <a href="#liv70279-bib-0015" class="usa-link" aria-describedby="liv70279-bib-0015">15</a>, <a href="#liv70279-bib-0016" class="usa-link" aria-describedby="liv70279-bib-0016">16</a>, <a href="#liv70279-bib-0017" class="usa-link" aria-describedby="liv70279-bib-0017">17</a>]. Infants with rapidly progressive LAL‐D treated with sebelipase alfa and adequate nutritional care survived and developed well compared with historical controls [<a href="#liv70279-bib-0018" class="usa-link" aria-describedby="liv70279-bib-0018">18</a>, <a href="#liv70279-bib-0019" class="usa-link" aria-describedby="liv70279-bib-0019">19</a>, <a href="#liv70279-bib-0020" class="usa-link" aria-describedby="liv70279-bib-0020">20</a>]. In children and adults with LAL‐D, sebelipase alfa treatment improved liver‐related disease measures such as the liver enzymes alanine aminotransferase (ALT) and aspartate aminotransferase (AST), liver volume, and liver fat content, as well as parameters of lipid metabolism, including low‐ and high‐density lipoprotein cholesterol levels [<a href="#liv70279-bib-0005" class="usa-link" aria-describedby="liv70279-bib-0005">5</a>, <a href="#liv70279-bib-0021" class="usa-link" aria-describedby="liv70279-bib-0021">21</a>, <a href="#liv70279-bib-0022" class="usa-link" aria-describedby="liv70279-bib-0022">22</a>].</p>
<p>The International LAL‐D Registry is an ongoing observational study initiated in 2013 to generate real‐world evidence of the natural history of LAL‐D [<a href="#liv70279-bib-0008" class="usa-link" aria-describedby="liv70279-bib-0008">8</a>]. Rare disease registries are powerful tools for assessing outcomes that are underreported in clinical trials owing to low patient numbers and providing valuable insights on the natural history of disease over time [<a href="#liv70279-bib-0023" class="usa-link" aria-describedby="liv70279-bib-0023">23</a>]. After the EU and US approval of sebelipase alfa in 2015, the registry was amended to include information on treatment status, effectiveness, and safety, further broadening the availability of LAL‐D data [<a href="#liv70279-bib-0008" class="usa-link" aria-describedby="liv70279-bib-0008">8</a>, <a href="#liv70279-bib-0024" class="usa-link" aria-describedby="liv70279-bib-0024">24</a>]. Results from registry analyses showed that baseline ALT and AST elevations and symptom onset at an early age correspond with more severe liver damage, while the AST‐to‐platelet ratio index is a poor predictor of disease severity in patients with LAL‐D [<a href="#liv70279-bib-0008" class="usa-link" aria-describedby="liv70279-bib-0008">8</a>, <a href="#liv70279-bib-0025" class="usa-link" aria-describedby="liv70279-bib-0025">25</a>]. The current analysis had two objectives: (1) describe ALT and AST among patients who were enrolled in the International LAL‐D Registry and were either untreated or treated with sebelipase alfa and (2) evaluate ALT and AST among treated and untreated patients at baseline and over 5 years of follow‐up.</p></section><section id="liv70279-sec-0010"><h2 class="pmc_sec_title">2. Methods</h2>
<section id="liv70279-sec-0011"><h3 class="pmc_sec_title">2.1. Registry Eligibility</h3>
<p>The International LAL‐D Registry is an ongoing, observational, multisite study to collect data on patients with LAL‐D, with the aim of improving patient outcomes [<a href="#liv70279-bib-0008" class="usa-link" aria-describedby="liv70279-bib-0008">8</a>]. The registry protocol was approved by the institutional review board, or equivalent, at each participating site and was conducted in accordance with all applicable government regulations, the Declaration of Helsinki, and the principles of the International Council for Harmonisation Guidelines for Good Clinical Practice. All patients enrolled in the registry, or their parent or guardian, provided informed consent and authorisation prior to submitting their data into the registry. The registry is sponsored by Alexion, AstraZeneca Rare Disease and is overseen by a scientific advisory board that includes medical experts with experience in LAL‐D research or patient care.</p></section><section id="liv70279-sec-0012"><h3 class="pmc_sec_title">2.2. Study Design</h3>
<p>The registry enrols patients of any age who have a confirmed diagnosis of LAL‐D, including living and deceased individuals regardless of whether they were treated with sebelipase alfa or untreated. The current analysis included patients who had a diagnosis of LAL‐D confirmed by <em>LIPA</em> genotype and/or low LAL enzyme activity; were alive at the time of registry enrollment; and had known sex, date of registry enrollment, sebelipase alfa treatment status (including date of treatment initiation if ever treated), and date of birth or age at registry enrollment. Patients in the longitudinal analysis were also required to have baseline and longitudinal measures of ALT and/or AST. Patients with rapidly progressive LAL‐D who initiated treatment with sebelipase alfa prior to 6 months of age and patients with prior participation in a clinical trial that included sebelipase alfa were excluded from this analysis so as to not introduce bias by including these patients' initial data in analyses from the registry. Adverse events were analysed among patients in the safety population, which included all patients enrolled in the registry who had ever been treated with sebelipase alfa. Patient data were analysed through a registry cutoff date of 2 October 2023.</p></section><section id="liv70279-sec-0013"><h3 class="pmc_sec_title">2.3. Demographics and Disease Outcomes</h3>
<p>Baseline demographic data were analysed for all patients included in the study. Baseline ALT and AST results were analysed by patient age and treatment status (treated or untreated with sebelipase alfa) and reported as multiples of the upper limit of normal (ULN) because ULNs are age‐ and sex‐specific and can vary by laboratory. Baseline for all analyses was defined as the date of first sebelipase alfa treatment for treated patients or the date of registry enrollment for those who were untreated. ALT and AST results were categorised as within normal limits (WNL; defined as ≤ ULN), &gt;ULN to &lt; 1.5 × ULN, ≥ 1.5 to &lt; 2 × ULN, ≥ 2 to &lt; 3 × ULN, or ≥ 3 × ULN. Patient age at baseline was categorised as 0 to &lt; 6 years, 6 to &lt; 12 years, 12 to &lt; 18 years, and ≥ 18 years. An analysis was performed using data from patients in the “Fixed Complete Cohort” to measure changes in ALT and AST over time in patients with regular monitoring. The Fixed Complete Cohort included treated and untreated patients who had ALT or AST values available at baseline and at each of the 3 consecutive annual follow‐up measurements. An additional cohort analysis was performed using data from patients who had ALT and AST values recorded at baseline and at ≥ 1 time point over 5 years of follow‐up. All adverse events (AEs) and serious AEs (SAEs) were recorded for treated patients throughout registry follow‐up.</p></section><section id="liv70279-sec-0014"><h3 class="pmc_sec_title">2.4. Statistical Analysis</h3>
<p>Results are summarised as median and interquartile range for continuous variables and as count and percentage for discrete variables. A repeated measures analysis using a linear mixed model regression provided estimates of the change in ALT and AST multiples of normal at each timepoint compared to baseline. Covariates in this analysis included treatment timepoint, age at baseline, and genotype. This analysis was performed using data from treated patients who were above the ULN at baseline and who had complete measurements at baseline and at each of the 3 consecutive annual follow‐up visits. The number of patients with results available for analysis throughout follow‐up varies owing to the observational nature of the registry in which patient data are collected in a real‐world setting under routine clinical care.</p></section></section><section id="liv70279-sec-0015"><h2 class="pmc_sec_title">3. Results</h2>
<section id="liv70279-sec-0016"><h3 class="pmc_sec_title">3.1. Study Population</h3>
<p>Of the 291 patients with LAL‐D who did not have rapidly progressive disease and were enrolled in the registry as of 2 October 2023, a total of 186 were included in this analysis; 125 had ever been treated with sebelipase alfa (“treated” patients) and 61 had never been treated with sebelipase alfa (“untreated” patients) (Figure <a href="#liv70279-supitem-0001" class="usa-link">S1</a>). The primary reason for exclusion from the current analysis was prior participation in a clinical trial that included sebelipase alfa (<em>n</em> = 58). Baseline characteristics of the study population are summarised in Table <a href="#liv70279-tbl-0001" class="usa-link">1</a>. About half of the patients in the analysis were male, and 93% were White. Median (quartile [Q]1, Q3) age at diagnosis was 10.3 (6.3, 21.1) years and was lower among treated patients (9.1 [5.9, 13.8]) than among those who were untreated (20.6 [8.5, 41.5]). Median (Q1, Q3) age at the time of registry enrollment was 14.4 (9.1, 26.4) years for all patients and was lower among treated patients (11.9 [7.6, 16.7]) than among those who were untreated (25.3 [18.9, 44.8]). Baseline ALT and AST levels also differed by treatment status. At baseline, ALT levels were above the ULN in 94% of treated patients and in 66% of untreated patients. Similarly, baseline AST levels were above the ULN in 87% of treated patients and in 57% of those who were untreated. Among patients in the overall study population whose <em>LIPA</em> genotype was analysed, 40% were homozygous for c.894G&gt;A variants.</p>
<section class="tw xbox font-sm" id="liv70279-tbl-0001"><h4 class="obj_head">TABLE 1.</h4>
<div class="caption p"><p>Baseline patient characteristics by sebelipase alfa treatment status.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom"><tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1">Description</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Treated patients (<em>n</em> = 125)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Untreated patients (<em>n</em> = 61)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Study population (<em>N</em> = 186)</th>
</tr></thead>
<tbody valign="top">
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Male, <em>n</em> (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">69 (55.2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">23 (37.7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">92 (49.5)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Patients with race data, <em>n</em> (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">120 (96.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">57 (93.4)</td>
<td align="center" valign="top" rowspan="1" colspan="1">177 (95.2)</td>
</tr>
<tr><td align="left" style="padding-left:10%" colspan="4" valign="top" rowspan="1">Race, <em>n</em> (%)</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">White</td>
<td align="center" valign="top" rowspan="1" colspan="1">111 (92.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">53 (93.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">164 (92.7)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Asian</td>
<td align="center" valign="top" rowspan="1" colspan="1">3 (2.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (1.8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">4 (2.3)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Other/multiple</td>
<td align="center" valign="top" rowspan="1" colspan="1">6 (5.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">3 (5.3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">9 (5.1)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Unknown or missing race, n</td>
<td align="center" valign="top" rowspan="1" colspan="1">5</td>
<td align="center" valign="top" rowspan="1" colspan="1">4</td>
<td align="center" valign="top" rowspan="1" colspan="1">9</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Age at diagnosis, median (Q1, Q3), years</td>
<td align="center" valign="top" rowspan="1" colspan="1">9.1 (5.9, 13.8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">20.6 (8.5, 41.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">10.3 (6.3, 21.1)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Age at registry enrollment, median (Q1, Q3), years</td>
<td align="center" valign="top" rowspan="1" colspan="1">11.9 (7.6, 16.7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">25.3 (18.9, 44.8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">14.4 (9.1, 26.4)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Patients with baseline ALT, <em>n</em> (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">104 (83.2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">58 (95.1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">162 (87.1)</td>
</tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">Baseline ALT&gt;ULN<a href="#liv70279-note-0004" class="usa-link">
<sup>a</sup>
</a>, <em>n</em> (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">98 (94.2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">38 (65.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">136 (84.0)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Patients with baseline AST, <em>n</em> (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">102 (81.6)</td>
<td align="center" valign="top" rowspan="1" colspan="1">49 (80.3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">151 (81.2)</td>
</tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">Baseline AST&gt;ULN<a href="#liv70279-note-0004" class="usa-link">
<sup>a</sup>
</a>, <em>n</em> (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">89 (87.3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">28 (57.1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">117 (77.5)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">
<em>LIPA</em> genotype data analysed, <em>n</em>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">108</td>
<td align="center" valign="top" rowspan="1" colspan="1">47</td>
<td align="center" valign="top" rowspan="1" colspan="1">155</td>
</tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">Homozygous for c.894G&gt;A, <em>n</em> (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">39 (36.1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">23 (48.9)</td>
<td align="center" valign="top" rowspan="1" colspan="1">62 (40.0)</td>
</tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">Homozygous for other variants, <em>n</em> (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">20 (18.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">6 (12.8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">26 (16.8)</td>
</tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">Compound heterozygous for c.894G&gt;A, <em>n</em> (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">35 (32.4)</td>
<td align="center" valign="top" rowspan="1" colspan="1">15 (31.9)</td>
<td align="center" valign="top" rowspan="1" colspan="1">50 (32.3)</td>
</tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">Compound heterozygous for other variants, <em>n</em> (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">14 (13.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2 (4.3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">16 (10.3)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/liv70279-tbl-0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="liv70279-note-0003"><p>Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; Q, quartile; ULN, upper limit of normal.</p></div>
<div class="fn" id="liv70279-note-0004">
<sup>
<sup>a</sup>
</sup><p class="display-inline">ULN for ALT and AST vary by age and sex.</p>
</div>
</div></section></section><section id="liv70279-sec-0017"><h3 class="pmc_sec_title">3.2. Baseline Aminotransferase Levels</h3>
<p>Of the 186 patients in the analysis, 162 (87%) and 151 (81%) had available baseline ALT and AST data. Results were categorised as WNL or as multiples of the ULN and stratified by age group. ALT and AST levels were above the ULN for most patients in all age groups. However, the elevations were more common and more pronounced among paediatric patients than among adult patients. ALT levels were above the ULN in 93% of children aged &lt; 18 years and in 68% of adults aged ≥ 18 years (Figure <a href="#liv70279-fig-0001" class="usa-link">1A</a>). AST levels followed a similar pattern, in which levels were above the ULN in 89% and 54% of children and adults, respectively (Figure <a href="#liv70279-fig-0001" class="usa-link">1B</a>).</p>
<figure class="fig xbox font-sm" id="liv70279-fig-0001"><h4 class="obj_head">FIGURE 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33fd/12334869/d82b6607e3b1/LIV-45-0-g003.jpg" loading="lazy" id="jats-graphic-1" height="375" width="709" alt="FIGURE 1"></p>
<div class="p text-right font-secondary"><a href="figure/liv70279-fig-0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Baseline ALT (<em>n</em> = 162) and AST (<em>n</em> = 151) values within normal limits and in multiples of the ULN stratified by age. ALT, alanine aminotransferase; AST, aspartate aminotransferase; ULN, upper limit of normal.</p></figcaption></figure><p>When analysing age as a continuous variable, age at baseline was inversely associated with ALT (<em>r</em> = −0.281; <em>p</em> = 0.0003) and AST (<em>r</em> = −0.478; <em>p</em> &lt; 0.0001) multiples of normal at baseline (Table <a href="#liv70279-tbl-0002" class="usa-link">2</a>). Genotype (c.[894G&gt;A];[894G&gt;A]) was significantly associated with ALT (<em>p</em> = 0.0194) and AST (<em>p</em> = 0.0096) multiples of normal at baseline (Table <a href="#liv70279-tbl-0002" class="usa-link">2</a>). There was no correlation between ALT or AST multiples of normal at baseline and sex (Table <a href="#liv70279-tbl-0002" class="usa-link">2</a>).</p>
<section class="tw xbox font-sm" id="liv70279-tbl-0002"><h4 class="obj_head">TABLE 2.</h4>
<div class="caption p"><p>Correlation analyses among all patients (treated or untreated) with baseline ALT or AST.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom"><tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1"></th>
<th align="center" valign="bottom" rowspan="1" colspan="1">
<em>N</em>
</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Mean (SD)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">
<em>r</em>
<sub>
<em>s</em>
</sub>
</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">
<em>p</em>
</th>
</tr></thead>
<tbody valign="top">
<tr><td align="left" colspan="5" valign="top" rowspan="1">ALT multiple of normal</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Age at baseline</td>
<td align="center" valign="top" rowspan="1" colspan="1">162</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.1 (1.26)</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.281</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0003</td>
</tr>
<tr><td align="left" style="padding-left:10%" colspan="5" valign="top" rowspan="1">Sex</td></tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">Female</td>
<td align="center" valign="top" rowspan="1" colspan="1">81</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.9 (1.20)</td>
<td align="center" valign="top" rowspan="1" colspan="1">—</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0837</td>
</tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">Male</td>
<td align="center" valign="top" rowspan="1" colspan="1">81</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.3 (1.30)</td>
<td align="center" valign="top" rowspan="1" colspan="1">—</td>
<td align="center" valign="top" rowspan="1" colspan="1">—</td>
</tr>
<tr><td align="left" style="padding-left:10%" colspan="5" valign="top" rowspan="1">Genotype</td></tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">Homozygous for c.894G&gt;A</td>
<td align="center" valign="top" rowspan="1" colspan="1">57</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.0 (1.04)</td>
<td align="center" valign="top" rowspan="1" colspan="1">—</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0194</td>
</tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">Homozygous for other variants</td>
<td align="center" valign="top" rowspan="1" colspan="1">23</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.5 (0.86)</td>
<td align="center" valign="top" rowspan="1" colspan="1">—</td>
<td align="center" valign="top" rowspan="1" colspan="1">—</td>
</tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">Compound heterozygous for c.894G&gt;A</td>
<td align="center" valign="top" rowspan="1" colspan="1">45</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.5 (1.70)</td>
<td align="center" valign="top" rowspan="1" colspan="1">—</td>
<td align="center" valign="top" rowspan="1" colspan="1">—</td>
</tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">Compound heterozygous for other variants</td>
<td align="center" valign="top" rowspan="1" colspan="1">14</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.5 (1.19)</td>
<td align="center" valign="top" rowspan="1" colspan="1">—</td>
<td align="center" valign="top" rowspan="1" colspan="1">—</td>
</tr>
<tr><td align="left" colspan="5" valign="top" rowspan="1">AST multiple of normal</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Age at baseline</td>
<td align="center" valign="top" rowspan="1" colspan="1">151</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.7 (0.94)</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.478</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.0001</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Sex</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">Female</td>
<td align="center" valign="top" rowspan="1" colspan="1">77</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.6 (0.97)</td>
<td align="center" valign="top" rowspan="1" colspan="1">—</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.9001</td>
</tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">Male</td>
<td align="center" valign="top" rowspan="1" colspan="1">74</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.7 (0.91)</td>
<td align="center" valign="top" rowspan="1" colspan="1">—</td>
<td align="center" valign="top" rowspan="1" colspan="1">—</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Genotype</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">Homozygous for c.894G&gt;A</td>
<td align="center" valign="top" rowspan="1" colspan="1">56</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.5 (0.60)</td>
<td align="center" valign="top" rowspan="1" colspan="1">—</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0096</td>
</tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">Homozygous for other variants</td>
<td align="center" valign="top" rowspan="1" colspan="1">22</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.5 (1.13)</td>
<td align="center" valign="top" rowspan="1" colspan="1">—</td>
<td align="center" valign="top" rowspan="1" colspan="1">—</td>
</tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">Compound heterozygous for c.894G&gt;A</td>
<td align="center" valign="top" rowspan="1" colspan="1">42</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.8 (0.98)</td>
<td align="center" valign="top" rowspan="1" colspan="1">—</td>
<td align="center" valign="top" rowspan="1" colspan="1">—</td>
</tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">Compound heterozygous for other variants</td>
<td align="center" valign="top" rowspan="1" colspan="1">14</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.3 (0.94)</td>
<td align="center" valign="top" rowspan="1" colspan="1">—</td>
<td align="center" valign="top" rowspan="1" colspan="1">—</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/liv70279-tbl-0002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="liv70279-note-0005"><p>Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase.</p></div></div></section></section><section id="liv70279-sec-0018"><h3 class="pmc_sec_title">3.3. Fixed Complete Cohort Analysis</h3>
<p>A subanalysis was performed among patients in the Fixed Complete Cohort, which included patients who had measures of ALT or AST at baseline and at each of 3 consecutive annual follow‐ups. A total of 75 patients (53 treated and 22 untreated) had ALT results at all time points, and 70 patients (51 treated and 19 untreated) had AST results at all time points. The demographics of treated patients in this cohort who had baseline ALT or AST levels &gt; ULN are summarised in Table <a href="#liv70279-supitem-0001" class="usa-link">S1</a>. Demographics were similar to those of treated patients from the overall study population.</p>
<p>Of the 53 treated patients in the Fixed Complete Cohort with ALT data, at baseline, 51 (96%) had ALT levels above the ULN (Figure <a href="#liv70279-fig-0002" class="usa-link">2A</a>). After 1 year of follow‐up, 22 of 53 (42%) treated patients had ALT levels WNL (Figure <a href="#liv70279-fig-0002" class="usa-link">2A</a>). Improvements in ALT were sustained among these patients, with ALT levels WNL in 20 of 53 (38%) patients at 3 years of follow‐up. Median ALT levels significantly decreased by 51.4% (95% CI: −59.3, −46.2) after 1 year, with similar results found over 3 years of treatment. AST improvements in treated patients followed a similar trend. Of the 51 treated patients in the Fixed Complete Cohort with AST data, 44 (86%) had AST levels above the ULN at baseline (Figure <a href="#liv70279-fig-0002" class="usa-link">2B</a>). AST levels were WNL in 25 of 51 (49%) and 28 of 51 (55%) treated patients at 1 year and 3 years of follow‐up, respectively. After 1 year of treatment, median AST levels decreased by 42.1% from baseline (95% CI: −49.0, −40.0), with similar results recorded throughout follow‐up. Among treated patients in the Fixed Complete Cohort, mean ALT and AST multiples of normal at baseline were not significantly different by age group at baseline (<em>p</em> = 0.3976 and 0.0729, respectively).</p>
<figure class="fig xbox font-sm" id="liv70279-fig-0002"><h4 class="obj_head">FIGURE 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33fd/12334869/4ba48fe11b0a/LIV-45-0-g002.jpg" loading="lazy" id="jats-graphic-3" height="331" width="709" alt="FIGURE 2"></p>
<div class="p text-right font-secondary"><a href="figure/liv70279-fig-0002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Proportion of treated patients with ALT and AST values WNL at baseline and at 3 consecutive annual follow‐up measures. ALT, alanine aminotransferase; AST, aspartate aminotransferase; ULN, upper limit of normal; WNL, within normal limits.</p></figcaption></figure><p>To account for the correlation of repeated measures within individuals, a linear mixed regression model was used to estimate the change in ALT and AST multiples of normal at each timepoint compared with baseline among treated patients in the Fixed Complete Cohort. ALT and AST decreased significantly from baseline at each follow‐up measure. In Year 1, ALT was lower by −1.4 multiples of normal (95% CI: −1.7, −1.0) and AST was lower by −0.8 multiples of normal (95% CI: −1.1, −0.5; Figure <a href="#liv70279-fig-0003" class="usa-link">3A,B</a>). In Year 2, ALT was lower by −1.2 multiples of normal (95% CI: −1.5, −0.9) and AST was lower by −0.8 multiple of normal (95% CI: −1.1, −0.6); and in Year 3, ALT was lower by −1.1 multiples of normal (95% CI: −1.5, −0.7) and AST was lower by −0.9 multiple of normal (95% CI: −1.1, −0.7).</p>
<figure class="fig xbox font-sm" id="liv70279-fig-0003"><h4 class="obj_head">FIGURE 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33fd/12334869/80ccf9cb99d4/LIV-45-0-g001.jpg" loading="lazy" id="jats-graphic-5" height="329" width="709" alt="FIGURE 3"></p>
<div class="p text-right font-secondary"><a href="figure/liv70279-fig-0003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>ALT and AST multiples of the ULN in patients treated with sebelipase alfa who had 3 consecutive annual follow‐up measures. Open circles represent outliers, black diamonds represent means, and dashed lines represent medians. ALT, alanine aminotransferase; AST, aspartate aminotransferase; Nobs, number of observations; ULN, upper limit of normal.</p></figcaption></figure><p>An adjusted repeated measures analysis was performed in treated patients in the Fixed Complete Cohort to assess potential correlations between liver outcomes and age at baseline, genotype, the interaction of age at baseline and treatment timepoint, and the interaction of age at baseline and genotype. Age at baseline and the interaction between age at baseline and treatment timepoint were not correlated with ALT multiples of normal (Table <a href="#liv70279-tbl-0003" class="usa-link">3</a>). However, the interaction between age at baseline and genotype (using the most commonly occurring genotype, c.[894G&gt;A];[894G&gt;A] as the reference) was correlated with ALT multiples of normal in treated patients in the Fixed Complete Cohort (<em>p</em> = 0.0475; Table <a href="#liv70279-tbl-0003" class="usa-link">3</a>). There were no significant correlations between AST multiples of normal and any factor assessed (Table <a href="#liv70279-tbl-0003" class="usa-link">3</a>).</p>
<section class="tw xbox font-sm" id="liv70279-tbl-0003"><h4 class="obj_head">TABLE 3.</h4>
<div class="caption p"><p>Adjusted repeated measures analysis among treated patients in the Fixed Complete Cohort at baseline.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom">
<tr style="border-bottom:solid 1px #000000">
<th align="left" rowspan="2" valign="bottom" colspan="1"></th>
<th align="center" colspan="2" valign="bottom" rowspan="1">ALT multiple of normal (<em>n</em> = 75)</th>
<th align="center" colspan="2" valign="bottom" rowspan="1">AST multiple of normal (<em>n</em> = 70)</th>
</tr>
<tr style="border-bottom:solid 1px #000000">
<th align="center" valign="bottom" rowspan="1" colspan="1">Estimate (95% CI)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">
<em>p</em>
</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Estimate (95% CI)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">
<em>p</em>
</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Treatment timepoint (baseline used as reference)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0015</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.0001</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Result at 1 year</td>
<td align="center" valign="top" rowspan="1" colspan="1">−1.4 (−2.0, −0.7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0001</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.8 (−1.3, −0.4)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0002</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Result at 2 years</td>
<td align="center" valign="top" rowspan="1" colspan="1">−1.0 (−1.5, −0.4)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0007</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.8 (−1.2, −0.4)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0003</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Result at 3 years</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.9 (−1.5, −0.2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0104</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.9 (−1.2, −0.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.0001</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Age at baseline</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0 (−0.1, 0.1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.9858</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0 (−0.1, 0.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.2926</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Genotype (homozygous for c.894G&gt;A used as reference)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0277</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">0.7638</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Homozygous for other variants</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.3 (0.7, 3.8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0047</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.5 (−0.7, 1.8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.4000</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Compound heterozygous for c.894G&gt;A</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0 (−0.5, 0.6)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.8593</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.1 (−0.5, 0.4)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.7910</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Compound heterozygous for other variants</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.3 (−1.3, 0.7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.5041</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.2 (−1.0, 0.6)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.6344</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Age at baseline × treatment timepoint (baseline used as reference)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">0.4291</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">0.7015</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Result at 1 year</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0 (0.0, 0.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.7108</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0 (0.0, 0.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.9645</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Result at 2 years</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0 (−0.1, 0.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.2726</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0 (0.0, 0.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.6873</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Result at 3 years</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0 (−0.1, 0.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.3124</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0 (0.0, 0.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.9326</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Age at baseline × genotype (homozygous for c.894G&gt;A used as reference)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0475</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">0.5984</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Homozygous for other variants</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.2 (−0.3, 0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0235</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0 (−0.2, 0.1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.4966</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Compound heterozygous for c.894G&gt;A</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0 (0.0, 0.1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.2600</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0 (0.0, 0.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.3109</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Compound heterozygous for other variants</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0 (−0.1, 0.2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.3999</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0 (−0.1, 0.1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.8226</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/liv70279-tbl-0003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="liv70279-note-0006"><p>Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase.</p></div></div></section><p>Of 22 untreated patients in the Fixed Complete Cohort with ALT results, 16 (73%) had ALT levels above the ULN at baseline (Figure <a href="#liv70279-supitem-0001" class="usa-link">S2A</a>). Four of these 22 patients had ALT levels WNL after 1 year of follow‐up, and 6 (27%) had ALT levels WNL after 3 years (Figure <a href="#liv70279-supitem-0001" class="usa-link">S2A</a>). Of 19 untreated patients in this cohort with AST results, 11 (58%) had AST levels above the ULN at baseline (Figure <a href="#liv70279-supitem-0001" class="usa-link">S2B</a>). Seven of 19 (37%) patients had AST levels WNL after 1 year (Figure <a href="#liv70279-supitem-0001" class="usa-link">S2B</a>); results were sustained over follow‐up. There was no appreciable change in ALT or AST multiples of normal over time in untreated patients from this cohort (Figure <a href="#liv70279-supitem-0001" class="usa-link">S3A,B</a>).</p></section><section id="liv70279-sec-0019"><h3 class="pmc_sec_title">3.4. 
ALT and AST After 5 Years of Follow‐Up</h3>
<p>While the Fixed Complete Cohort had a large number of patients assessed through 3 years of follow‐up, the number of patients with results through 5 consecutive years was considerably smaller. Thus, changes in aminotransferase levels over 5 years of follow‐up were analysed in a discrete cohort of patients. Cohorts of patients at each year of follow‐up were reported based on the availability of aminotransferase data at baseline and analysis year. Among treated patients with aminotransferase results at baseline and at 1 year of follow‐up, median percent changes in ALT and AST levels were −49% (95% CI: −52.7, −35.3; <em>n</em> = 78) and −41% (95% CI: −44.0, −31.4; <em>n</em> = 76), respectively (Figure <a href="#liv70279-fig-0004" class="usa-link">4A,B</a>). Similar significant decreases were found in each cohort over 5 years of follow‐up. Among untreated patients with baseline data, changes in ALT and AST levels did not follow a consistent pattern over time (Figure <a href="#liv70279-supitem-0001" class="usa-link">S4A,B</a>).</p>
<figure class="fig xbox font-sm" id="liv70279-fig-0004"><h4 class="obj_head">FIGURE 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33fd/12334869/ceba5d55a8ad/LIV-45-0-g004.jpg" loading="lazy" id="jats-graphic-7" height="323" width="709" alt="FIGURE 4"></p>
<div class="p text-right font-secondary"><a href="figure/liv70279-fig-0004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Percent change in ALT and AST over 5 years of follow‐up in patients treated with sebelipase alfa. *Significant based on 95% CIs. ALT, alanine aminotransferase; AST, aspartate aminotransferase.</p></figcaption></figure></section><section id="liv70279-sec-0020"><h3 class="pmc_sec_title">3.5. Safety</h3>
<p>A total of 137 patients treated with sebelipase alfa were included in the safety analysis. The frequency of AEs in treated patients is summarised in Table <a href="#liv70279-tbl-0004" class="usa-link">4</a>. Throughout the study, 80 of 137 patients (58%) experienced at least 1 AE, which were mostly mild to moderate in severity, and 7 (5%) experienced infusion‐associated reactions. One infusion‐associated reaction (nonsevere anaphylactic reaction that resolved the same day) was deemed serious and treatment related. There were a total of 18 SAEs in 16 patients during follow‐up. All SAEs besides the nonsevere anaphylactic reaction were deemed non–treatment related and included pyrexia and appendicitis occurring in 2 patients each (1 of whom had acute ulcerated appendicitis) and infectious mononucleosis, laryngeal squamous cell carcinoma, renal colic, dyspnea, tracheitis, pneumonia, arthropathy, juvenile spondyloarthritis, syncope, tonsillitis, meningitis herpes, 
<em>Clostridium difficile</em>
 colitis, and hepatocellular carcinoma occurring in 1 patient each. One patient experienced febrile seizures on 3 separate occasions; however, none of these events occurred during registry follow‐up. No deaths occurred during follow‐up.</p>
<section class="tw xbox font-sm" id="liv70279-tbl-0004"><h4 class="obj_head">TABLE 4.</h4>
<div class="caption p"><p>Adverse events among patients treated with sebelipase alfa.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<thead valign="bottom"><tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1">Adverse event description, <em>n</em> (%), number of events</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Patients (<em>n</em> = 137)<a href="#liv70279-note-0008" class="usa-link">
<sup>a</sup>
</a>
</th>
</tr></thead>
<tbody valign="top">
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Patients with ≥ 1 AE</td>
<td align="center" valign="top" rowspan="1" colspan="1">80 (58.4), 280</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Patients with ≥ 1 infusion‐associated reactions</td>
<td align="center" valign="top" rowspan="1" colspan="1">7 (5.1), 22</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Patients with ≥ 1 SAE</td>
<td align="center" valign="top" rowspan="1" colspan="1">16 (11.7), 18</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Patients with ≥ 1 treatment‐related SAE</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (0.7), 1</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Deaths</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/liv70279-tbl-0004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="liv70279-note-0007"><p>Abbreviations: AE, adverse event; SAE, serious adverse event.</p></div>
<div class="fn" id="liv70279-note-0008">
<sup>
<sup>a</sup>
</sup><p class="display-inline">Safety population (<em>n</em> = 137) includes all patients enrolled in the registry who had ever been treated with sebelipase alfa.</p>
</div>
</div></section></section></section><section id="liv70279-sec-0021"><h2 class="pmc_sec_title">4. Discussion</h2>
<p>This analysis of the International LAL‐D Registry assessed ALT and AST levels over time as indicators of liver injury in patients with LAL‐D and the clinical impact of enzyme replacement therapy with sebelipase alfa on aminotransferase levels among treated patients. Treated patients were diagnosed at an earlier age than untreated patients and had more pronounced elevations of ALT and AST levels above the ULN at baseline. Treated patients had significant improvements in ALT and AST levels over time, with results sustained for up to 5 years of follow‐up. Untreated patients had fluctuations in ALT and AST levels over time. Overall, these findings suggest that treated patients have a more severe phenotype than untreated patients and that sebelipase alfa treatment normalises aminotransferase levels among patients who are at increased risk of progressing to liver disease in real‐world practice.</p>
<p>ALT and AST are both commonly measured in patients with LAL‐D [<a href="#liv70279-bib-0011" class="usa-link" aria-describedby="liv70279-bib-0011">11</a>, <a href="#liv70279-bib-0021" class="usa-link" aria-describedby="liv70279-bib-0021">21</a>, <a href="#liv70279-bib-0022" class="usa-link" aria-describedby="liv70279-bib-0022">22</a>, <a href="#liv70279-bib-0026" class="usa-link" aria-describedby="liv70279-bib-0026">26</a>]. Evaluation of aminotransferases, particularly ALT, is also relevant for the assessment of patients with any of a wide array of other hepatic conditions, including metabolic dysfunction−associated steatotic liver disease, autoimmune hepatitis, and hepatitis B infection [<a href="#liv70279-bib-0027" class="usa-link" aria-describedby="liv70279-bib-0027">27</a>]. The US Food and Drug Administration recommends including ALT as an efficacy endpoint during the development of novel therapies for hepatitis B infection, highlighting the important role of this aminotransferase in monitoring liver outcomes [<a href="#liv70279-bib-0028" class="usa-link" aria-describedby="liv70279-bib-0028">28</a>]. Aminotransferases are also routinely assessed in comprehensive metabolic panels, making them an accessible outcome for monitoring disease progression.</p>
<p>The current analysis shows that paediatric patients diagnosed with LAL‐D have a more severe phenotype (as demonstrated by more pronounced elevations in ALT and AST levels) than patients diagnosed in adulthood. There was a significant inverse correlation between age and aminotransferase levels. The data presented in this manuscript are in line with the results of previous literature indicating that diagnosis of LAL‐D at a young age is associated with a more severe phenotype [<a href="#liv70279-bib-0001" class="usa-link" aria-describedby="liv70279-bib-0001">1</a>, <a href="#liv70279-bib-0018" class="usa-link" aria-describedby="liv70279-bib-0018">18</a>]. A previous analysis of patients in the International LAL‐D Registry also showed an inverse relationship between patient age and fibrosis score, with patients &lt; 12 years of age having more advanced fibrosis than those ≥ 12 years of age, collectively suggesting that patients with LAL‐D who present at an earlier age have more severe liver outcomes than adult patients [<a href="#liv70279-bib-0025" class="usa-link" aria-describedby="liv70279-bib-0025">25</a>].</p>
<p>The current analysis also shows that aminotransferase levels improved in paediatric and adult patients with LAL‐D who were treated with sebelipase alfa in real‐world practice. In all age categories, sebelipase alfa treatment increased the proportion of patients with aminotransferase levels WNL after 1 year of follow‐up. In the Fixed Complete Cohort, which included patients with baseline aminotransferase values above the ULN and data from 3 consecutive years of follow‐up, 41% had ALT and AST results WNL after 1 year. These results show that sebelipase alfa treatment results in normalisation of AST and ALT levels in more severely affected patients who were treated in real‐world practice. These findings are of particular interest since they provide a better understanding of changes in liver assessments over time in patients with regular monitoring, especially for those treated with sebelipase alfa. The findings concur with those of a previous randomised clinical trial and open‐label extension of sebelipase alfa in 59 children and adults with LAL‐D in which ALT levels normalised after treatment in 47% of patients [<a href="#liv70279-bib-0021" class="usa-link" aria-describedby="liv70279-bib-0021">21</a>]. Among treated patients in this study, ALT and AST levels were reduced from baseline by 49% and 41%, respectively, after 1 year of follow‐up, and reductions were similar in each unique cohort assessed over 5 years of follow‐up. Sebelipase alfa treatment decreased ALT and AST levels to a similar extent in open‐label extension studies with 3 to 5 years of follow‐up [<a href="#liv70279-bib-0005" class="usa-link" aria-describedby="liv70279-bib-0005">5</a>, <a href="#liv70279-bib-0021" class="usa-link" aria-describedby="liv70279-bib-0021">21</a>, <a href="#liv70279-bib-0022" class="usa-link" aria-describedby="liv70279-bib-0022">22</a>]. Although the number of patients analysed at each time point over the 5‐year follow‐up in this study varied because of real‐world data collection, the observed decreases in ALT and AST support the ongoing beneficial effect of sebelipase alfa treatment. Overall, the results of this manuscript confirm the results found in clinical trials and may provide reassurance to clinicians that sebelipase alfa treatment is effective in routine clinical practice.</p>
<p>This study has limitations. While it reports outcomes in treated and untreated patients, these 2 cohorts had markedly different clinical features at baseline; therefore, results in the two groups have limited comparisons with one another. As such, this study does not have a comparator arm and instead uses longitudinal measures of ALT and AST to characterise treatment effectiveness. The registry contains data only from real‐world follow‐up of patients. While data on liver or cardiac events (e.g., liver fibrosis/cirrhosis, portal hypertension, ischemic heart disease) are documented as part of real‐world patient follow‐up, these outcomes are infrequent, thus limiting extrapolation of ALT or AST data to clinical outcomes. While the registry collects data on LAL enzyme activity at diagnosis, enzyme activity is not routinely measured over time in clinical practice. As such, only baseline enzyme activity is available among registry patients. However, the registry does have complete and robust data on other variables, including demographics, genetic test results, and treatment status. The number of patients with data throughout follow‐up is variable because data are collected under routine clinical care in real‐world settings. Some analyses were performed on small sub‐populations of patients, potentially limiting interpretation of the results. Consistent with the known demographics of patients with LAL‐D, this study population primarily included White patients (93%).</p></section><section id="liv70279-sec-0022"><h2 class="pmc_sec_title">5. Conclusions</h2>
<p>The results of this registry analysis contribute evidence to a growing body of literature on the natural history of LAL‐D and the effectiveness of ERT with sebelipase alfa. While most patients had ALT and AST levels above the ULN at baseline, patients who received sebelipase alfa treatment were more likely to have pronounced ALT and AST elevations at baseline than those who were untreated. Treated patients with ALT and AST levels above the ULN at baseline had significant reductions in both measures over time, leading to normalisation of each aminotransferase level in 41% of patients after 1 year of treatment. These data suggest that enzyme replacement therapy with sebelipase alfa is likely to improve long‐term liver outcomes in patients with LAL‐D and warrant continued longitudinal investigation of LAL‐D in a larger cohort.</p></section><section id="liv70279-sec-0024"><h2 class="pmc_sec_title">Author Contributions</h2>
<p>All authors contributed to the study and the development and/or subsequent revision of the manuscript. All authors read and approved the final manuscript for submission. The International LAL‐D Registry is sponsored by Alexion, AstraZeneca Rare Disease, and is overseen by a scientific advisory board that includes medical experts with experience in LAL‐D research or patient care.</p></section><section id="liv70279-sec-0028"><h2 class="pmc_sec_title">Ethics Statement</h2>
<p>The International LAL‐D Registry (<a href="https://clinicaltrials.gov/ct2/show/NCT01633489" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT01633489</a>, EUPAS13276) protocol was approved by the institutional review board, or equivalent, at each participating site and was conducted in accordance with all applicable government regulations, the Declaration of Helsinki, and the principles of the International Council for Harmonisation Guidelines for Good Clinical Practice.</p></section><section id="liv70279-sec-0029"><h2 class="pmc_sec_title">Consent</h2>
<p>All patients enrolled in the registry or their next of kin, if applicable, provided informed consent and authorization prior to submitting their data into the registry.</p></section><section id="liv70279-sec-0023"><h2 class="pmc_sec_title">Conflicts of Interest</h2>
<p>Lorenzo D’Antiga, Emilio Ros, Manisha Balwani, Don P Wilson and William Balistreri are consultants/members of the Alexion, Astra Zeneca Rare Disease LAL‐d registry Advisory Board. Jennifer Evans and Florian Abel are employed by Alexion, Astra Zeneca Rare Disease.</p></section><section id="sec24"><h2 class="pmc_sec_title">Supporting information</h2>
<section class="sm xbox font-sm" id="liv70279-supitem-0001"><div class="caption p"><p>
<strong>Data S1:</strong> liv70279‐sup‐0001‐Supinfo1.docx.</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12334869/bin/LIV-45-0-s001.docx" data-ga-action="click_feat_suppl" class="usa-link">LIV-45-0-s001.docx</a><sup> (350.2KB, docx) </sup>
</div></div></section></section><section id="liv70279-sec-0025" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>We thank the patients and their families for their participation in this study, as well as all of the health care professionals who provided care for these patients.</p></section><section id="notes1"><p>

D'Antiga L., Evans J., Ros E., et al., “Sebelipase Alfa Improves Aminotransferase Levels in Lysosomal Acid Lipase Deficiency: Data From an International Registry,” Liver International
45, no. 9 (2025): e70279, 10.1111/liv.70279.
</p>
<section id="liv70279-ntgp-0001" class="fn-group"><div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="liv70279-note-0001"><p>
<strong>Funding:</strong> This study was sponsored by Alexion, AstraZeneca Rare Disease. Editorial and writing support was provided by Violet Kiesel, PhD, of Peloton Advantage LLC, an OPEN Health company and was funded by Alexion, AstraZeneca Rare Disease.</p></div>
<div class="fn p" id="liv70279-note-0002"><p>Jennifer Evans—At time of the study.</p></div>
</div></section></section><section id="liv70279-sec-0027"><h2 class="pmc_sec_title">Data Availability Statement</h2>
<p>Alexion, AstraZeneca Rare Disease will consider requests for disclosure of clinical study participant‐level data provided that participant privacy is assured through methods like data de‐identification, pseudonymization, or anonymization (as required by applicable law), and if such disclosure was included in the relevant study informed consent form or similar documentation. Qualified academic investigators may request participant‐level clinical data and supporting documents (statistical analysis plan and protocol) pertaining to Alexion‐sponsored studies. Further details regarding data availability and instructions for requesting information are available in the Alexion Clinical Trials Disclosure and Transparency Policy at <a href="https://www.alexionclinicaltrialtransparency.com/data-requests/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.alexionclinicaltrialtransparency.com/data‐requests/</a>.</p></section><section id="liv70279-bibl-0001" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="liv70279-bibl-0001_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="liv70279-bib-0001">
<span class="label">1.</span><cite>
Grabowski G. A., Valayannopoulos V., Goodman Z. D., and Balwani M., “Lysosomal Acid Lipase Deficiency: The Continuous Spectra of Disease Variants,” in The Online Metabolic and Molecular Bases of Inherited Disease, ed. Valle D., Beaudet A. L., Vogelstein B., et al. (McGraw‐Hill, 2019).</cite> [<a href="https://scholar.google.com/scholar_lookup?title=The%20Online%20Metabolic%20and%20Molecular%20Bases%20of%20Inherited%20Disease&amp;author=G.%20A.%20Grabowski&amp;author=V.%20Valayannopoulos&amp;author=Z.%20D.%20Goodman&amp;author=M.%20Balwani&amp;publication_year=2019&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70279-bib-0002">
<span class="label">2.</span><cite>
Rader D. J., “Lysosomal Acid Lipase Deficiency ‐ a New Therapy for a Genetic Lipid Disease,” New England Journal of Medicine
373, no. 11 (2015): 1071–1073, 10.1056/NEJMe1509055.
</cite> [<a href="https://doi.org/10.1056/NEJMe1509055" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26352819/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=New%20England%20Journal%20of%20Medicine&amp;title=Lysosomal%20Acid%20Lipase%20Deficiency%20%E2%80%90%20a%20New%20Therapy%20for%20a%20Genetic%20Lipid%20Disease&amp;author=D.%20J.%20Rader&amp;volume=373&amp;issue=11&amp;publication_year=2015&amp;pages=1071-1073&amp;pmid=26352819&amp;doi=10.1056/NEJMe1509055&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70279-bib-0003">
<span class="label">3.</span><cite>
Reiner Z., Guardamagna O., Nair D., et al., “Lysosomal Acid Lipase Deficiency—An Under‐Recognized Cause of Dyslipidaemia and Liver Dysfunction,” Atherosclerosis
235, no. 1 (2014): 21–30, 10.1016/j.atherosclerosis.2014.04.003.
</cite> [<a href="https://doi.org/10.1016/j.atherosclerosis.2014.04.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24792990/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Atherosclerosis&amp;title=Lysosomal%20Acid%20Lipase%20Deficiency%E2%80%94An%20Under%E2%80%90Recognized%20Cause%20of%20Dyslipidaemia%20and%20Liver%20Dysfunction&amp;author=Z.%20Reiner&amp;author=O.%20Guardamagna&amp;author=D.%20Nair&amp;volume=235&amp;issue=1&amp;publication_year=2014&amp;pages=21-30&amp;pmid=24792990&amp;doi=10.1016/j.atherosclerosis.2014.04.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70279-bib-0004">
<span class="label">4.</span><cite>
Bernstein D. L., Hulkova H., Bialer M. G., and Desnick R. J., “Cholesteryl Ester Storage Disease: Review of the Findings in 135 Reported Patients With an Underdiagnosed Disease,” Journal of Hepatology
58, no. 6 (2013): 1230–1243, 10.1016/j.jhep.2013.02.014.
</cite> [<a href="https://doi.org/10.1016/j.jhep.2013.02.014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23485521/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Hepatology&amp;title=Cholesteryl%20Ester%20Storage%20Disease:%20Review%20of%20the%20Findings%20in%20135%20Reported%20Patients%20With%20an%20Underdiagnosed%20Disease&amp;author=D.%20L.%20Bernstein&amp;author=H.%20Hulkova&amp;author=M.%20G.%20Bialer&amp;author=R.%20J.%20Desnick&amp;volume=58&amp;issue=6&amp;publication_year=2013&amp;pages=1230-1243&amp;pmid=23485521&amp;doi=10.1016/j.jhep.2013.02.014&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70279-bib-0005">
<span class="label">5.</span><cite>
Malinová V., Balwani M., Sharma R., et al., “Sebelipase Alfa for Lysosomal Acid Lipase Deficiency: 5‐Year Treatment Experience From a Phase 2 Open‐Label Extension Study,” Liver International
40, no. 9 (2020): 2203–2214, 10.1111/liv.14603.
</cite> [<a href="https://doi.org/10.1111/liv.14603" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7540377/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32657505/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Liver%20International&amp;title=Sebelipase%20Alfa%20for%20Lysosomal%20Acid%20Lipase%20Deficiency:%205%E2%80%90Year%20Treatment%20Experience%20From%20a%20Phase%202%20Open%E2%80%90Label%20Extension%20Study&amp;author=V.%20Malinov%C3%A1&amp;author=M.%20Balwani&amp;author=R.%20Sharma&amp;volume=40&amp;issue=9&amp;publication_year=2020&amp;pages=2203-2214&amp;pmid=32657505&amp;doi=10.1111/liv.14603&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70279-bib-0006">
<span class="label">6.</span><cite>
Jones S. A., Banikazemi M., Bialer M., et al., “Rapid Progression and Mortality of Lysosomal Acid Lipase Deficiency Presenting in Infants,” Genetics in Medicine
18, no. 5 (2016): 452–458, 10.1038/gim.2015.108.
</cite> [<a href="https://doi.org/10.1038/gim.2015.108" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4857209/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26312827/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genetics%20in%20Medicine&amp;title=Rapid%20Progression%20and%20Mortality%20of%20Lysosomal%20Acid%20Lipase%20Deficiency%20Presenting%20in%20Infants&amp;author=S.%20A.%20Jones&amp;author=M.%20Banikazemi&amp;author=M.%20Bialer&amp;volume=18&amp;issue=5&amp;publication_year=2016&amp;pages=452-458&amp;pmid=26312827&amp;doi=10.1038/gim.2015.108&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70279-bib-0007">
<span class="label">7.</span><cite>
Sheth S., Toth P. P., Baum S. J., and Aggarwal M., “Distinguishing Lysosomal Acid Lipase Deficiency From Familial Hypercholesterolemia,” JACC Case Report
24 (2023): 102023, 10.1016/j.jaccas.2023.102023.</cite> [<a href="https://doi.org/10.1016/j.jaccas.2023.102023" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10589441/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37869222/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JACC%20Case%20Report&amp;title=Distinguishing%20Lysosomal%20Acid%20Lipase%20Deficiency%20From%20Familial%20Hypercholesterolemia&amp;author=S.%20Sheth&amp;author=P.%20P.%20Toth&amp;author=S.%20J.%20Baum&amp;author=M.%20Aggarwal&amp;volume=24&amp;publication_year=2023&amp;pages=102023&amp;pmid=37869222&amp;doi=10.1016/j.jaccas.2023.102023&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70279-bib-0008">
<span class="label">8.</span><cite>
Balwani M., Balistreri W., D'Antiga L., et al., “Lysosomal Acid Lipase Deficiency Manifestations in Children and Adults: Baseline Data From an International Registry,” Liver International
43 (2023): 1537–1547, 10.1111/liv.15620.
</cite> [<a href="https://doi.org/10.1111/liv.15620" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37222260/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Liver%20International&amp;title=Lysosomal%20Acid%20Lipase%20Deficiency%20Manifestations%20in%20Children%20and%20Adults:%20Baseline%20Data%20From%20an%20International%20Registry&amp;author=M.%20Balwani&amp;author=W.%20Balistreri&amp;author=L.%20D'Antiga&amp;volume=43&amp;publication_year=2023&amp;pages=1537-1547&amp;pmid=37222260&amp;doi=10.1111/liv.15620&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70279-bib-0009">
<span class="label">9.</span><cite>
Partin J. C. and Schubert W. K., “Small Intestinal Mucosa in Cholesterol Ester Storage Disease. A Light and Electron Microscope Study,” Gastroenterology
57, no. 5 (1969): 542–558.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/5348089/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gastroenterology&amp;title=Small%20Intestinal%20Mucosa%20in%20Cholesterol%20Ester%20Storage%20Disease.%20A%20Light%20and%20Electron%20Microscope%20Study&amp;author=J.%20C.%20Partin&amp;author=W.%20K.%20Schubert&amp;volume=57&amp;issue=5&amp;publication_year=1969&amp;pages=542-558&amp;pmid=5348089&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70279-bib-0010">
<span class="label">10.</span><cite>
Besler K. J., Blanchard V., and Francis G. A., “Lysosomal Acid Lipase Deficiency: A Rare Inherited Dyslipidemia but Potential Ubiquitous Factor in the Development of Atherosclerosis and Fatty Liver Disease,” Frontiers in Genetics
13 (2022): 1013266, 10.3389/fgene.2022.1013266.
</cite> [<a href="https://doi.org/10.3389/fgene.2022.1013266" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9530988/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36204319/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Genetics&amp;title=Lysosomal%20Acid%20Lipase%20Deficiency:%20A%20Rare%20Inherited%20Dyslipidemia%20but%20Potential%20Ubiquitous%20Factor%20in%20the%20Development%20of%20Atherosclerosis%20and%20Fatty%20Liver%20Disease&amp;author=K.%20J.%20Besler&amp;author=V.%20Blanchard&amp;author=G.%20A.%20Francis&amp;volume=13&amp;publication_year=2022&amp;pages=1013266&amp;pmid=36204319&amp;doi=10.3389/fgene.2022.1013266&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70279-bib-0011">
<span class="label">11.</span><cite>
Burton B. K., Deegan P. B., Enns G. M., et al., “Clinical Features of Lysosomal Acid Lipase Deficiency—A Longitudinal Assessment of 48 Children and Adults,” Journal of Pediatric Gastroenterology and Nutrition
61, no. 6 (2015): 619–625, 10.1097/MPG.0000000000000935.
</cite> [<a href="https://doi.org/10.1097/MPG.0000000000000935" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4645959/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26252914/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Pediatric%20Gastroenterology%20and%20Nutrition&amp;title=Clinical%20Features%20of%20Lysosomal%20Acid%20Lipase%20Deficiency%E2%80%94A%20Longitudinal%20Assessment%20of%2048%20Children%20and%20Adults&amp;author=B.%20K.%20Burton&amp;author=P.%20B.%20Deegan&amp;author=G.%20M.%20Enns&amp;volume=61&amp;issue=6&amp;publication_year=2015&amp;pages=619-625&amp;pmid=26252914&amp;doi=10.1097/MPG.0000000000000935&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70279-bib-0012">
<span class="label">12.</span><cite>
Alexion Pharmaceuticals
, “Kanuma (Sebelipase Alfa). Alexion Pharmaceuticals Inc,” (2024).</cite>
</li>
<li id="liv70279-bib-0013">
<span class="label">13.</span><cite>
Pharma A
, “Kanuma Canada. Alexion Pharma GmbH,” (2017).</cite>
</li>
<li id="liv70279-bib-0014">
<span class="label">14.</span><cite>
Europe A., “Kanuma (Sebelipase Alfa). Levallois‐Perret. France Alexion Europe,” (2020).</cite>
</li>
<li id="liv70279-bib-0015">
<span class="label">15.</span><cite>
Alexion Pharma Godo Kaisha
, “Japan K. Kanuma Japan,” (2016).</cite>
</li>
<li id="liv70279-bib-0016">
<span class="label">16.</span><cite>
Australasia A. P., “Kanuma Australia. Alexion Pharmaceuticals Australasia,” (2023).</cite>
</li>
<li id="liv70279-bib-0017">
<span class="label">17.</span><cite>
“Sebelipase Alfa for Treating Wolman Disease,” (2024), <a href="https://www.nice.org.uk/guidance/hst30/chapter/1-Recommendations" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.nice.org.uk/guidance/hst30/chapter/1‐Recommendations</a>.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/40203161/" class="usa-link">PubMed</a>]</li>
<li id="liv70279-bib-0018">
<span class="label">18.</span><cite>
Jones S. A., Rojas‐Caro S., Quinn A. G., et al., “Survival in Infants Treated With Sebelipase Alfa for Lysosomal Acid Lipase Deficiency: An Open‐Label, Multicenter, Dose‐Escalation Study,” Orphanet Journal of Rare Diseases
12 (2017): 25, 10.1186/s13023-017-0587-3.
</cite> [<a href="https://doi.org/10.1186/s13023-017-0587-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5299659/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28179030/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Orphanet%20Journal%20of%20Rare%20Diseases&amp;title=Survival%20in%20Infants%20Treated%20With%20Sebelipase%20Alfa%20for%20Lysosomal%20Acid%20Lipase%20Deficiency:%20An%20Open%E2%80%90Label,%20Multicenter,%20Dose%E2%80%90Escalation%20Study&amp;author=S.%20A.%20Jones&amp;author=S.%20Rojas%E2%80%90Caro&amp;author=A.%20G.%20Quinn&amp;volume=12&amp;publication_year=2017&amp;pages=25&amp;pmid=28179030&amp;doi=10.1186/s13023-017-0587-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70279-bib-0019">
<span class="label">19.</span><cite>
Vijay S., Brassier A., Ghosh A., et al., “Long‐Term Survival With Sebelipase Alfa Enzyme Replacement Therapy in Infants With Rapidly Progressive Lysosomal Acid Lipase Deficiency: Final Results From 2 Open‐Label Studies,” Orphanet Journal of Rare Diseases
16, no. 1 (2021): 13, 10.1186/s13023-020-01577-4.
</cite> [<a href="https://doi.org/10.1186/s13023-020-01577-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7789691/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33407676/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Orphanet%20Journal%20of%20Rare%20Diseases&amp;title=Long%E2%80%90Term%20Survival%20With%20Sebelipase%20Alfa%20Enzyme%20Replacement%20Therapy%20in%20Infants%20With%20Rapidly%20Progressive%20Lysosomal%20Acid%20Lipase%20Deficiency:%20Final%20Results%20From%202%20Open%E2%80%90Label%20Studies&amp;author=S.%20Vijay&amp;author=A.%20Brassier&amp;author=A.%20Ghosh&amp;volume=16&amp;issue=1&amp;publication_year=2021&amp;pages=13&amp;pmid=33407676&amp;doi=10.1186/s13023-020-01577-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70279-bib-0020">
<span class="label">20.</span><cite>
Demaret T., Lacaille F., Wicker C., et al., “Sebelipase Alfa Enzyme Replacement Therapy in Wolman Disease: A Nationwide Cohort With up to Ten Years of Follow‐Up,” Orphanet Journal of Rare Diseases
16, no. 1 (2021): 507, 10.1186/s13023-021-02134-3.
</cite> [<a href="https://doi.org/10.1186/s13023-021-02134-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8670257/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34906190/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Orphanet%20Journal%20of%20Rare%20Diseases&amp;title=Sebelipase%20Alfa%20Enzyme%20Replacement%20Therapy%20in%20Wolman%20Disease:%20A%20Nationwide%20Cohort%20With%20up%20to%20Ten%20Years%20of%20Follow%E2%80%90Up&amp;author=T.%20Demaret&amp;author=F.%20Lacaille&amp;author=C.%20Wicker&amp;volume=16&amp;issue=1&amp;publication_year=2021&amp;pages=507&amp;pmid=34906190&amp;doi=10.1186/s13023-021-02134-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70279-bib-0021">
<span class="label">21.</span><cite>
Burton B. K., Feillet F., Furuya K. N., Marulkar S., and Balwani M., “Sebelipase Alfa in Children and Adults With Lysosomal Acid Lipase Deficiency: Final Results of the ARISE Study,” Journal of Hepatology
76, no. 3 (2022): 577–587, 10.1016/j.jhep.2021.10.026.
</cite> [<a href="https://doi.org/10.1016/j.jhep.2021.10.026" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34774639/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Hepatology&amp;title=Sebelipase%20Alfa%20in%20Children%20and%20Adults%20With%20Lysosomal%20Acid%20Lipase%20Deficiency:%20Final%20Results%20of%20the%20ARISE%20Study&amp;author=B.%20K.%20Burton&amp;author=F.%20Feillet&amp;author=K.%20N.%20Furuya&amp;author=S.%20Marulkar&amp;author=M.%20Balwani&amp;volume=76&amp;issue=3&amp;publication_year=2022&amp;pages=577-587&amp;pmid=34774639&amp;doi=10.1016/j.jhep.2021.10.026&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70279-bib-0022">
<span class="label">22.</span><cite>
Burton B. K., Sanchez A. C., Kostyleva M., et al., “Long‐Term Sebelipase Alfa Treatment in Children and Adults With Lysosomal Acid Lipase Deficiency,” Journal of Pediatric Gastroenterology and Nutrition
74, no. 6 (2022): 757–764, 10.1097/mpg.0000000000003452.
</cite> [<a href="https://doi.org/10.1097/mpg.0000000000003452" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35442238/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Pediatric%20Gastroenterology%20and%20Nutrition&amp;title=Long%E2%80%90Term%20Sebelipase%20Alfa%20Treatment%20in%20Children%20and%20Adults%20With%20Lysosomal%20Acid%20Lipase%20Deficiency&amp;author=B.%20K.%20Burton&amp;author=A.%20C.%20Sanchez&amp;author=M.%20Kostyleva&amp;volume=74&amp;issue=6&amp;publication_year=2022&amp;pages=757-764&amp;pmid=35442238&amp;doi=10.1097/mpg.0000000000003452&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70279-bib-0023">
<span class="label">23.</span><cite>
Hageman I. C., van Rooij I., de Blaauw I., Trajanovska M., and King S. K., “A Systematic Overview of Rare Disease Patient Registries: Challenges in Design, Quality Management, and Maintenance,” Orphanet Journal of Rare Diseases
18, no. 1 (2023): 106, 10.1186/s13023-023-02719-0.
</cite> [<a href="https://doi.org/10.1186/s13023-023-02719-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10163740/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37147718/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Orphanet%20Journal%20of%20Rare%20Diseases&amp;title=A%20Systematic%20Overview%20of%20Rare%20Disease%20Patient%20Registries:%20Challenges%20in%20Design,%20Quality%20Management,%20and%20Maintenance&amp;author=I.%20C.%20Hageman&amp;author=I.%20van%20Rooij&amp;author=I.%20de%20Blaauw&amp;author=M.%20Trajanovska&amp;author=S.%20K.%20King&amp;volume=18&amp;issue=1&amp;publication_year=2023&amp;pages=106&amp;pmid=37147718&amp;doi=10.1186/s13023-023-02719-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70279-bib-0024">
<span class="label">24.</span><cite>
Shirley M., “Sebelipase Alfa: First Global Approval,” Drugs
75, no. 16 (2015): 1935–1940, 10.1007/s40265-015-0479-6.
</cite> [<a href="https://doi.org/10.1007/s40265-015-0479-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26452566/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drugs&amp;title=Sebelipase%20Alfa:%20First%20Global%20Approval&amp;author=M.%20Shirley&amp;volume=75&amp;issue=16&amp;publication_year=2015&amp;pages=1935-1940&amp;pmid=26452566&amp;doi=10.1007/s40265-015-0479-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70279-bib-0025">
<span class="label">25.</span><cite>
Balistreri W. F., Evans J., Abel F., and D'Antiga L., “Correlation Between Age and Progression of Liver Disease in Patients With Lysosomal Acid Lipase Deficiency (LAL‐D): Data From the International LAL‐D Registry [Abstract 3311‐A],” Hepatology
78, no. S1 (2023): S1493–S1494.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Hepatology&amp;title=Correlation%20Between%20Age%20and%20Progression%20of%20Liver%20Disease%20in%20Patients%20With%20Lysosomal%20Acid%20Lipase%20Deficiency%20(LAL%E2%80%90D):%20Data%20From%20the%20International%20LAL%E2%80%90D%20Registry%20%5BAbstract%203311%E2%80%90A%5D&amp;author=W.%20F.%20Balistreri&amp;author=J.%20Evans&amp;author=F.%20Abel&amp;author=L.%20D'Antiga&amp;volume=78&amp;issue=S1&amp;publication_year=2023&amp;pages=S1493-S1494&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70279-bib-0026">
<span class="label">26.</span><cite>
Burton B., Balwani M., Feillet F., et al., “A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency,” New England Journal of Medicine
373, no. 11 (2015): 1010–1020, 10.1056/NEJMoa1501365.
</cite> [<a href="https://doi.org/10.1056/NEJMoa1501365" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26352813/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=New%20England%20Journal%20of%20Medicine&amp;title=A%20Phase%203%20Trial%20of%20Sebelipase%20Alfa%20in%20Lysosomal%20Acid%20Lipase%20Deficiency&amp;author=B.%20Burton&amp;author=M.%20Balwani&amp;author=F.%20Feillet&amp;volume=373&amp;issue=11&amp;publication_year=2015&amp;pages=1010-1020&amp;pmid=26352813&amp;doi=10.1056/NEJMoa1501365&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70279-bib-0027">
<span class="label">27.</span><cite>
Liu Z., Que S., Xu J., and Peng T., “Alanine Aminotransferase‐Old Biomarker and New Concept: A Review,” International Journal of Medical Sciences
11, no. 9 (2014): 925–935, 10.7150/ijms.8951.
</cite> [<a href="https://doi.org/10.7150/ijms.8951" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4081315/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25013373/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Journal%20of%20Medical%20Sciences&amp;title=Alanine%20Aminotransferase%E2%80%90Old%20Biomarker%20and%20New%20Concept:%20A%20Review&amp;author=Z.%20Liu&amp;author=S.%20Que&amp;author=J.%20Xu&amp;author=T.%20Peng&amp;volume=11&amp;issue=9&amp;publication_year=2014&amp;pages=925-935&amp;pmid=25013373&amp;doi=10.7150/ijms.8951&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70279-bib-0028">
<span class="label">28.</span><cite>
“Chronic Hepatitis B Virus Infection: Developing Drugs for Treatment Guidance for Industry,” (2022), <a href="https://www.fda.gov/media/117977/download" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.fda.gov/media/117977/download</a>.</cite>
</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p"><p>
<strong>Data S1:</strong> liv70279‐sup‐0001‐Supinfo1.docx.</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12334869/bin/LIV-45-0-s001.docx" data-ga-action="click_feat_suppl" class="usa-link">LIV-45-0-s001.docx</a><sup> (350.2KB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>Alexion, AstraZeneca Rare Disease will consider requests for disclosure of clinical study participant‐level data provided that participant privacy is assured through methods like data de‐identification, pseudonymization, or anonymization (as required by applicable law), and if such disclosure was included in the relevant study informed consent form or similar documentation. Qualified academic investigators may request participant‐level clinical data and supporting documents (statistical analysis plan and protocol) pertaining to Alexion‐sponsored studies. Further details regarding data availability and instructions for requesting information are available in the Alexion Clinical Trials Disclosure and Transparency Policy at <a href="https://www.alexionclinicaltrialtransparency.com/data-requests/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.alexionclinicaltrialtransparency.com/data‐requests/</a>.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Liver International are provided here courtesy of <strong>Wiley</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1111/liv.70279"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/LIV-45-0.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (545.5 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12334869/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12334869/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12334869%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12334869/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12334869/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12334869/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40781810/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12334869/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40781810/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12334869/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12334869/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="6k1hhgTOqbLFcf83pnRcaeUOzEESv1Cqo9RkWKsAMOpNoN4IYRr1lwUDJ1zoDDho">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Web Policies

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    FOIA

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS Vulnerability Disclosure

    
</a>

                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Help

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Accessibility

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Careers

    
</a>

                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NLM

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NIH

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    USA.gov

    
</a>

                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-370d5dd6.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-917ba005.js"></script>
    
    

    </body>
</html>
